L.B. Marks

Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831

Michele Y. Halyard, Thomas M. Pisansky, Amylou C. Dueck et al. · Journal of Clinical Oncology · 2009 · 186 citations · Full text

Medicine, Oncology, Radiation Oncology +17

International Marketing Ethics: Problems Encountered byAustralian Firms

Robert W. Armstrong, Bruce W. Stening, John K. Ryans et al. · European Journal of Marketing · 1990 · 49 citations

Business, International Business, Marketing +9

Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer?

Erica N Evans, Zafer Koçak, S. Zhou et al. · Cytokine · 2006 · 41 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Consolidation with High-Dose Combination Alkylating Agents with Bone Marrow Transplantation Significantly Improves Disease-Free Survival in Hormone-Insensitive Metastatic Breast Cancer in Complete Remission Compared with Intensive Standard-Dose Chemotherapy Alone

James J. Vredenburgh, David Coniglio, Gloria Broadwater et al. · Biology of Blood and Marrow Transplantation · 2006 · 30 citations

Medicine, Oncology, Breast Oncology +14

125 Radiation pneumonitis as a function of dose and volume; An analysis of pooled data of 442 patients

Joos V. Lebesque, Stefan L.S. Kwa, Jacqueline Theuws et al. · International Journal of Radiation Oncology*Biology*Physics · 1997 · 22 citations

Medicine, Oncology, Radiation Oncology +14